NEUROLOGY 2005;64:1920-1924
© 2005 American Academy of Neurology
Restless legs syndrome
A community-based study of prevalence, severity, and risk factors
B. Högl, MD,
S. Kiechl, MD,
J. Willeit, MD,
M. Saletu, MD,
B. Frauscher, MD,
K. Seppi, M,
J. Müller, MD,
G. Rungger, MD,
A. Gasperi, MD,
G. Wenning, PhD and
W. Poewe, MD
From the Department of Neurology (Drs. Högl, Kiechl, Willeit, Saletu, Frauscher, Seppi, Müller, Wenning, and Poewe), Innsbruck Medical University, Austria; and Department of Neurology (Drs. Rungger and Gasperi), Bruneck Medical Hospital, Bruneck, Italy.
Address correspondence and reprint requests to Dr. Werner Poewe, Department of Neurology, Innsbruck Medical University, Anichstr. 35, 6020 Innsbruck, Austria; e-mail: werner.poewe{at}uibk.ac.at
Objective: To assess the prevalence and severity of restless legs syndrome (RLS) in the general community and to investigate its potential relationship with iron metabolism and other potential risk factors.
Methods: This was a cross-sectional study of a sex- and age-stratified random sample of the general population (50 to 89 years; n = 701). The diagnosis of RLS was established by face-to-face interviews; severity was graded on the RLS severity scale. Each subject underwent a thorough clinical examination and extensive laboratory testing.
Results: The prevalence of RLS was 10.6% (14.2% in women, 6.6% in men); 33.8% of all patients with RLS had mild, 44.6% had moderate, and 21.6% had severe disease expression. None had been previously diagnosed or was on dopaminergic therapy. Free serum iron, transferrin, and ferritin concentrations were similar in subjects with and without RLS. However, soluble transferrin receptor (sTR) concentrations were different in subjects with and without RLS (1.48 vs 1.34 mg/L; p < 0.001). Female sex and high sTR independently predicted the risk of RLS.
Conclusion: This large survey confirms the high prevalence, female preponderance, and underrecognition of restless legs syndrome in the general community. Although two-thirds of patients had moderate to severe disease, none was on current dopaminergic therapy.
The Bruneck Study was supported by Pustertaler Verein zur Prävention von Herz- und Hirngefaesserkrankungen, Sanitaetseinheit Ost, and Assessorat fuer Gesundheit, Province of Bolzano, Italy.
Received December 21, 2004. Accepted in final form March 2, 2005.
This article has been cited by other articles:
|
|
|
|
 
J. H. Jhoo, I. -Y. Yoon, Y. K. Kim, S. Chung, J. -M. Kim, S. B. Lee, T. H. Kim, S. H. Moon, S. E. Kim, and K. W. Kim
Availability of brain serotonin transporters in patients with restless legs syndrome
Neurology,
February 9, 2010;
74(6):
513 - 518.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Celle, F. Roche, J. Kerleroux, C. Thomas-Anterion, B. Laurent, I. Rouch, V. Pichot, J. C. Barthelemy, and E. Sforza
Prevalence and Clinical Correlates of Restless Legs Syndrome in an Elderly French Population: The Synapse Study
J Gerontol A Biol Sci Med Sci,
February 1, 2010;
65A(2):
167 - 173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Aitken, G. Gorman, R. McFarland, M. Roberts, R. W. Taylor, and D. M. Turnbull
Clinical Reasoning: Blurred vision and dancing feet: Restless legs syndrome presenting in mitochondrial disease
Neurology,
May 5, 2009;
72(18):
e86 - e90.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Hattan, C. Chalk, and R. B. Postuma
Is there a higher risk of restless legs syndrome in peripheral neuropathy?
Neurology,
March 17, 2009;
72(11):
955 - 960.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Hogl, C. Trenkwalder, W. Poewe, T. A. Crozier, D. Karimdadian, and S. Happe
More on the Restless Legs Syndrome and Spinal Anesthesia
N. Engl. J. Med.,
March 12, 2009;
360(11):
1155 - 1156.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Schwaiger, S Kiechl, K Seppi, M Sawires, H Stockner, T Erlacher, M. Mairhofer, H Niederkofler, G Rungger, A Gasperi, et al.
Prevalence of Primary Headaches and Cranial Neuralgias in Men and Women Aged 55-94 Years (Bruneck Study)
Cephalalgia,
February 1, 2009;
29(2):
179 - 187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Winkelman, E. Shahar, I. Sharief, and D. J. Gottlieb
Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study
Neurology,
January 1, 2008;
70(1):
35 - 42.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ryan and J. T. Slevin
Restless Legs Syndrome
Journal of Pharmacy Practice,
December 1, 2007;
20(6):
430 - 448.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Rhode, V. Hosing, S Happe, K Biehl, P Young, and S Evers
Comorbidity of Migraine and Restless Legs Syndrome--A Case-Control Study
Cephalalgia,
November 1, 2007;
27(11):
1255 - 1260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Picchietti, R. P. Allen, A. S. Walters, J. E. Davidson, A. Myers, and L. Ferini-Strambi
Restless Legs Syndrome: Prevalence and Impact in Children and Adolescents The Peds REST Study
Pediatrics,
August 1, 2007;
120(2):
253 - 266.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.J. Gomez-Choco, A. Iranzo, Y. Blanco, F. Graus, J. Santamaria, and A. Saiz
Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis
Multiple Sclerosis,
July 1, 2007;
13(6):
805 - 808.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. E. Gamaldo and C. J. Earley
Restless legs syndrome: a clinical update.
Chest,
November 1, 2006;
130(5):
1596 - 1604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R. Castillo, J. Kaplan, S.-C. Lin, P. A. Fredrickson, and M. W. Mahowald
Prevalence of Restless Legs Syndrome Among Native South Americans Residing in Coastal and Mountainous Areas
Mayo Clin. Proc.,
October 1, 2006;
81(10):
1345 - 1347.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Merlino, A. Piani, P. Dolso, M. Adorati, I. Cancelli, M. Valente, and G. L. Gigli
Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy
Nephrol. Dial. Transplant.,
January 1, 2006;
21(1):
184 - 190.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
